🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
Despite recent advances in the treatment of Castrate-Resistant Prostate Can...
Status
Completed
Location
Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust,
Start Date
2016-12
Trial ID
NCT02324998
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791
Real-world clinical outcomes and toxicity data will be evaluated in patient...
Status
Unknown
Location
Adamantia Nikolaidi
Start Date
2019-11-01
Trial ID
NCT04724031
Treatments Being Tested
A Phase I of Olaparib with Radiation Therapy in Patients With Inflammatory,...
Status
Completed
Location
Institut Curie
Start Date
2017-07-24
Trial ID
NCT03109080
Treatments Being Tested
A Single Arm Phase II Trial of BMN 673 for Inoperable, Advanced Endometrial...
Status
Withdrawn
Location
Royal Sussex County Hospital
Start Date
2014-10-01
Trial ID
NCT02127151
Treatments Being Tested
The purpose of this study is to find out whether talazoparib in combination...
Status
Recruiting
Location
City of Hope
Start Date
2026-05-04
Trial ID
NCT06844383
Treatments Being Tested
This phase I trial studies the side effects and best dose of veliparib when...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2012-12-07
Trial ID
NCT01749397
Treatments Being Tested
To investigate the safety and efficacy of preoperative moderately fractiona...
Status
Completed
Location
Beijing Jishuitan Hospital
Start Date
2023-05-01
Trial ID
NCT05938374
Treatments Being Tested
This pilot phase I trial studies whether it is feasible to conduct a detail...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2018-05-03
Trial ID
NCT03544125
Treatments Being Tested